• Home
  • Search Results
  • The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor.

Nature (1987-02-19)
J Kang, H G Lemaire, A Unterbeck, J M Salbaum, C L Masters, K H Grzeschik, G Multhaup, K Beyreuther, B Müller-Hill

Alzheimer's disease is characterized by a widespread functional disturbance of the human brain. Fibrillar amyloid proteins are deposited inside neurons as neurofibrillary tangles and extracellularly as amyloid plaque cores and in blood vessels. The major protein subunit (A4) of the amyloid fibril of tangles, plaques and blood vessel deposits is an insoluble, highly aggregating small polypeptide of relative molecular mass 4,500. The same polypeptide is also deposited in the brains of aged individuals with trisomy 21 (Down's syndrome). We have argued previously that the A4 protein is of neuronal origin and is the cleavage product of a larger precursor protein. To identify this precursor, we have now isolated and sequenced an apparently full-length complementary DNA clone coding for the A4 polypeptide. The predicted precursor consists of 695 residues and contains features characteristic of glycosylated cell-surface receptors. This sequence, together with the localization of its gene on chromosome 21, suggests that the cerebral amyloid deposited in Alzheimer's disease and aged Down's syndrome is caused by aberrant catabolism of a cell-surface receptor.

Product Number
Product Description

Amyloid Precursor Protein β, Secreted human, recombinant, expressed in E. coli (N-terminal histidine tagged), solution
Monoclonal Anti-β-Amyloid antibody produced in mouse, clone BAM-10, ascites fluid
Anti-APP Antibody, APP 643-695 CT fragment, clone 2.F2.19B4, ascites fluid, clone 2.F2.19B4, Chemicon®

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.